Company news

CytoSorbents Corporation news in 2022

CytoSorbents Corporation's news releases, calls and decks from 2022, newest first.

View company

CytoSorbents Receives $5M in Non-Dilutive Debt Financing from Bridge Bank and Extends Loan Agreement

December 28, 2022

CytoSorbents Receives Recommendation from Independent Data and Safety Monitoring Board to Continue Pivotal STAR-T Trial As Planned Without Modifications

December 20, 2022

CytoSorbents Announces Pivotal STAR-T Trial Reaches First Milestone With 40 Patients Enrolled

November 13, 2022

CytoSorbents Reports Third Quarter 2022 Financial and Operational Results

November 2, 2022

CytoSorbents to Report Third Quarter 2022 Operating and Financial Results

October 26, 2022

CytoSorbents Reports New Cardiac Surgery Data with CytoSorb at the European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

October 11, 2022

CytoSorbents Announces Pending Retirement of Chief Financial Officer Kathleen P. Bloch

October 6, 2022

CytoSorbents Awarded an Approximately $4.3M Contract by the U.S. Department of Defense to Develop HemoDefend-BGA™ for Freeze-Dried Universal Plasma

October 5, 2022

CytoSorbents Achieves ISO 13485 Certification of Princeton Manufacturing Facility in New Jersey

September 26, 2022

CytoSorbents Reports Second Quarter 2022 Financial and Operational Results

August 1, 2022

CytoSorbents to Hold 2022 Annual Meeting of Stockholders Virtually

June 1, 2022

CytoSorbents Partners with Nikkiso to Distribute the PureADJUST Hemoperfusion Blood Pump and Supplies in 14 Countries

May 31, 2022

CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook

May 2, 2022

CytoSorbents Awarded Preferred Supplier Agreement with Asklepios, One of the Largest Private Hospital Operators in Germany

May 1, 2022

First Patient Enrolled in U.S. STAR-D Pivotal Trial Evaluating the DrugSorb™-ATR Antithrombotic Removal System to Remove Apixaban and Rivaroxaban During Cardiothoracic Surgery

April 28, 2022

CytoSorbents Highlights the Strategy of "Enhanced Lung Rest" Using CytoSorb with ECMO to Help Treat Lung Failure at the 10th EuroELSO Congress

April 27, 2022

CytoSorbents to Report First Quarter 2022 Operating and Financial Results

April 18, 2022

CytoSorbents To Expand Direct Sales of CytoSorb® to the United Kingdom, the Sixth Largest Medical Device Market in the World

April 13, 2022

CytoSorbents Appoints Jiny Kim, MBA to its Board of Directors

April 4, 2022

CytoSorbents Reports Fourth Quarter and Full Year 2021 Results and Provides 2022 Outlook

March 7, 2022

CytoSorbents Announces Participation in Two Upcoming Virtual Investor Conferences

February 2, 2022

CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2021 Revenue

January 17, 2022

Calls in 2022

Decks in 2022